Both company’s collaborators will have access to Bioserve’s Global Repository and NeoCodex’ human specimens from the Spanish population.

Bioserve and NeoCodex entered a joint distribution deal through which collaborators working with both companies will gain expanded access to human samples.

Under this agreement, BioServe will be able to provide clinically annotated human specimens from the homogenous Spanish population. NeoCodex reportedly has a nationwide network capable of acquiring DNA, FFPE’s (fixed-formalin paraffin-embedded tissue), fluids, and tissues.

In return, NeoCodex gains access to BioServe’s Global Repository, a library of over 600,000 human DNA, tissue, and serum samples linked to clinical and demographic data from 140,000 consented and anonymized patients collected from four continents.

Previous articleSontra Medical and Echo Therapeutics Merge
Next articlebioMérieux to Design Companion Test for Ipsen Breast Cancer Compound